Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Interest & Investment Income: 2009-2025

Historic Interest & Investment Income for UNITED THERAPEUTICS (UTHR) over the last 13 years, with Sep 2025 value amounting to $46.4 million.

  • UNITED THERAPEUTICS's Interest & Investment Income fell 6.83% to $46.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.1 million, marking a year-over-year decrease of 1.34%. This contributed to the annual value of $199.1 million for FY2024, which is 22.37% up from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Interest & Investment Income stood at $46.4 million for Q3 2025, which was down 9.55% from $51.3 million recorded in Q2 2025.
  • UNITED THERAPEUTICS's Interest & Investment Income's 5-year high stood at $53.8 million during Q1 2024, with a 5-year trough of $3.8 million in Q3 2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $49.3 million (2024), whereas its average is $46.4 million.
  • In the last 5 years, UNITED THERAPEUTICS's Interest & Investment Income plummeted by 53.00% in 2021 and then skyrocketed by 579.07% in 2023.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Interest & Investment Income stood at $4.2 million in 2021, then spiked by 395.24% to $20.8 million in 2022, then spiked by 145.19% to $51.0 million in 2023, then decreased by 3.33% to $49.3 million in 2024, then decreased by 6.83% to $46.4 million in 2025.
  • Its Interest & Investment Income stands at $46.4 million for Q3 2025, versus $51.3 million for Q2 2025 and $51.1 million for Q1 2025.